ATTACHMENT L Letter from Shields Warren to Leslie Redman, March 5, 1951 BMM:CLD March 5, 1951 Mr. Leslie M. Redman "D" Division Los Alamos National Laboratory Atomic Energy Commission Los Alamos, New Mexico Dear Mr. Redman: Dr. Alberto F. Thompson, Chief, Technical Information Service, has asked me to reply to your letter of January 22, 1951, concerning policies on human experimentation. The following statements have guided the Division of Biology and Medicine in its attitude towards this problem: First, in a letter from Carroll Wilson, General Manager, to Dr. Robert Stone, University of California, dated November 5, 1947, appears the following from a statement prepared for Commissioners by the Advisory Committee for Biology and Medicine: "We therefore wish to record our approval of the position taken by the medical staff of the AEC in point of their studies of the substances dangerous to human life. We believe that no substances known to be, or suspected of being, poisonous or harmful should be given to human beings unless all of the following conditions be fully met: (a) that a reasonable hope exists that the administration of such a substance will improve the condition of the patient, (b) that the patient give his complete and informed consent in writing, and (c) that the responsible nearest of kin give in writing a similarly complete and informed consent, revocable at any time during the course of such treatment." Secondly, the Report of the Medical Board of Review dated June 20, 1947, on page 11, Section VI, first paragraph states: "Secrecy in scientific research is distasteful and in the long run is contrary to the best interests of scientific progress. The Board of Review recommends that insofar as it is compatible with national security, secrecy in the field of biological and medical research be avoided." Mr. Leslie W. Redman - 2 - March 5, 1951 Thirdly, Dr. Alan Gregg, Chairman of the Advisory Committee for the Division of Biology and Medicine stated at the September 1948 meeting of the Committee: "The secrecy with which some of the work of the Atomic Energy Commission has to be conducted creates special conditions for the clinical aspects of its work in that the public is aware of this necessity for secrecy and of the subsequent difficulty of probing into it." With these basic ideas in mind as guiding principles, I would like also to urge you the importance of having any experimental work which involves human beings supervised by an M.D. This holds equally well for self-experimentation by scientists whether or not they are physicians. If in the latter category, any such self- experimentation should be done only under the supervision of any physician. Sincerely yours, Shields Warren, M.D. Director Director of Biology and Medicine DUNHAM:mar Leslie M. Redman is Technical Advisor in Ralph Carlisle Smith's office. (Smith being Associate Director of D Division - patent attorney - has control over all classified information, patents, documents, etc., from the University).